BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21067379)

  • 1. Four-dollar generics--increased accessibility, impaired quality assurance.
    Choudhry NK; Shrank WH
    N Engl J Med; 2010 Nov; 363(20):1885-7. PubMed ID: 21067379
    [No Abstract]   [Full Text] [Related]  

  • 2. PBMs' rebate income threatened by lawsuits and move to generics.
    Sipkoff M
    Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152
    [No Abstract]   [Full Text] [Related]  

  • 3. Mass customization--the next generation of pharmacy management.
    Chao S
    Am J Manag Care; 2003 Sep; Suppl Decison Maker News():5-7. PubMed ID: 14567452
    [No Abstract]   [Full Text] [Related]  

  • 4. Facing the next challenge of pharmaceutical care: patient noncompliance.
    Bloom DL
    Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point/counterpoint. The HMO pharmacy benefit. In-house pharmacy administration: the benefits of integration.
    Penna P
    HMO; 1995; 36(4):56, 58-9. PubMed ID: 10166487
    [No Abstract]   [Full Text] [Related]  

  • 6. A changing order for pharmacy.
    Vogenberg FR; Pisano DJ
    Hosp Pharm; 1995 Nov; 30(11):1002, 1005-6, 1008. PubMed ID: 10152915
    [No Abstract]   [Full Text] [Related]  

  • 7. Recently introduced generics helped PBM control its costs.
    Manag Care; 2005 Nov; 14(11):77. PubMed ID: 16350653
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employers want plans & PBMs to push hard for generics.
    Sipkoff M
    Manag Care; 2007 Jan; 16(1):15-6. PubMed ID: 17285807
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of generic-only drug coverage in a Medicare HMO.
    Christian-Herman J; Emons M; George D
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-455-68. PubMed ID: 15471765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising strategies help employers integrate pharmacy and medical programs--and reap cost, quality advantages.
    Miller W
    Empl Benefits J; 2001 Sep; 26(3):23-7. PubMed ID: 11534217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare prescription drug coverage (part D): challenges and opportunities.
    Witten B
    Nephrol News Issues; 2006 Aug; 20(9):14-6, 18. PubMed ID: 16916055
    [No Abstract]   [Full Text] [Related]  

  • 13. The state and consequences of dermatology drug prices in the United States.
    Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
    J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
    [No Abstract]   [Full Text] [Related]  

  • 14. European countries with small populations can obtain low prices for drugs: Lithuania as a case history.
    Garuoliene K; Godman B; Gulbinovič J; Wettermark B; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):343-9. PubMed ID: 21671703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programs take the edge off pharmacy cost increases.
    Capitation Manag Rep; 2002 Apr; 9(4):53-6, 49. PubMed ID: 12004735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug trend slows in 2003, but higher utilization still driving costs.
    Capitation Rates Data; 2004 Jul; 9(7):78-82. PubMed ID: 15341340
    [No Abstract]   [Full Text] [Related]  

  • 17. Employer and Plan Sponsor Views on Pharmacy Reimbursement.
    Stull M; Gupton C
    J Manag Care Spec Pharm; 2020 Jun; 26(6):710-712. PubMed ID: 32463776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A balancing act. How to juggle pharmacy costs and quality care.
    Gong J; Webster T
    Contemp Longterm Care; 1999 May; 22(5):suppl 17-8. PubMed ID: 10537396
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy benefits management and ambulatory pharmacy services.
    Strandberg LR
    Pharm Pract Manag Q; 1996 Jan; 15(4):19-26. PubMed ID: 10153841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.